We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$31.5M
AUM Growth
-$25.7M
Cap. Flow
-$27.4M
Cap. Flow %
-86.72%
Top 10 Hldgs %
82.06%
Holding
68
New
8
Increased
1
Reduced
1
Closed
46

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.24M
2
SE icon
Sea Limited
SE
+$3.66M
3
OXY icon
Occidental Petroleum
OXY
+$1.88M
4
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$1.76M
5
NTCO
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
+$1.48M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$8.01M
2
EXE
Expand Energy Corp
EXE
+$3.73M
3
RDNT icon
RadNet
RDNT
+$2.1M
4
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$1.97M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$1.68M

Sector Composition

Rank Sector Weight
1 Energy 25.16%
2 Healthcare 20.26%
3 Materials 19.45%
4 Consumer Discretionary 14.72%
5 Technology 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BABA icon
26
Alibaba
BABA
$308B
– –
-9,800
Closed -$863K
BILL icon
27
BILL Holdings
BILL
$4.78B
– –
-10,940
Closed -$1.19M
CCJ icon
28
Cameco
CCJ
$42.4B
– –
-25,700
Closed -$583K
DAWN
29
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-27,223
Closed -$586K
DTIL icon
30
Precision BioSciences
DTIL
$207M
– –
-6,336
Closed -$226K
EQT icon
31
EQT Corp
EQT
$32.3B
– –
-12,200
Closed -$413K
GBIO
32
DELISTED
Generation Bio
GBIO
– –
-5,113
Closed -$201K
HRTX icon
33
Heron Therapeutics
HRTX
$92.9M
– –
-318,008
Closed -$795K
HTHT icon
34
Huazhu Hotels Group
HTHT
$13B
– –
-31,000
Closed -$1.32M
KALV
35
DELISTED
KalVista Pharmaceuticals
KALV
– –
-52,790
Closed -$357K
LRMR icon
36
Larimar Therapeutics
LRMR
$432M
– –
-63,680
Closed -$263K
MLTX icon
37
MoonLake Immunotherapeutics
MLTX
$1.55B
– –
-32,129
Closed -$337K
MSOS icon
38
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
– –
-202,000
Closed -$1.41M
OPTN
39
DELISTED
OptiNose
OPTN
– –
-26,316
Closed -$730K
OXY icon
40
CALL
Occidental Petroleum
OXY
$55.9B
– –
-302
Closed -$536K
PCVX icon
41
Vaxcyte
PCVX
$8.64B
– –
-26,849
Closed -$1.29M
PLRX icon
42
Pliant Therapeutics
PLRX
$65M
– –
-66,144
Closed -$1.28M
PTCT icon
43
PTC Therapeutics
PTCT
$6.12B
– –
-15,106
Closed -$577K
RARE icon
44
Ultragenyx Pharmaceutical
RARE
$2.55B
– –
-17,115
Closed -$793K
RAPT
45
DELISTED
RAPT Therapeutics
RAPT
– –
-8,979
Closed -$1.42M
RDNT icon
46
RadNet
RDNT
$5.69B
– –
-111,427
Closed -$2.1M
RRC icon
47
Range Resources
RRC
$8.95B
– –
-9,000
Closed -$225K
SRPT icon
48
Sarepta Therapeutics
SRPT
$1.77B
– –
-3,650
Closed -$473K
TVTX icon
49
Travere Therapeutics
TVTX
$5.78B
– –
-23,750
Closed -$499K
VERV
50
DELISTED
Verve Therapeutics
VERV
– –
-15,000
Closed -$290K
1
2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return
TCM
TORQ Capital Management Hong Kong $38.1M AUM 2.81% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Cheyne Capital Management (UK)'s Q1 2023 Portfolio in Review

As of Q1 2023, Cheyne Capital Management (UK) held 68 positions worth $31.5M, down 45% from $57.2M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Cheyne Capital Management (UK) withdrew a net $27.4M in Q1 2023, closing 46 positions and reducing 1 holding. Its most notable exit was Activision Blizzard, an estimated $8.01M position sold in full.

By sector, the portfolio is most concentrated in Energy at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Cheyne Capital Management (UK) opened a new position in Eli Lilly worth $6.35M.

  • Cheyne Capital Management (UK)'s largest Q1 2023 buy was Eli Lilly: 18,500 shares worth $6.35M.
  • Cheyne Capital Management (UK) added most to Occidental Petroleum in Q1 2023, an estimated $1.88M increase.
  • Cheyne Capital Management (UK)'s biggest Q1 2023 reduction was Uber, cutting an estimated $292K.
  • Cheyne Capital Management (UK) fully exited Activision Blizzard in Q1 2023, selling an estimated $8.01M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 82% of its $31.5M portfolio in Q1 2023.
  • Cheyne Capital Management (UK) opened 8 new positions and closed 46 in Q1 2023.
  • Cheyne Capital Management (UK)'s portfolio value fell 45% quarter-over-quarter to $31.5M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2023, filed 3 May 2023.